Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bicara Therapeutics Inc. BCAX

Set alert

Price alert · BCAX

All alert types
8.46 USD +0.53 +6.68%

As of Nov 3, 9:40 AM ET

Bid
8.32 × 4
Ask
8.50 × 4
7.90 Day range 8.53
7.87 52-week range 30.99
YTD
-49.73%
1 year
-47.06%
Open
8.03
Prev close
7.93
Mkt cap
561.61M
Vol
58.39K
Avg vol
1.06M
EPS
-3.08
P/E
0.00
Div yield
0.00%
More statistics
Low
7.90
High
8.53
Forward P/E
-4.96
Beta
-0.69
Short ratio
16.85
Inst. own
102.47%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
20.82
200-d avg
21.33
1y target
35.67

5m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (102)
NameTimeAgo
RSI: OversoldNov 2, 3:50 PM17 hours ago
MACD: Sell SignalNov 2, 3:35 PM18 hours ago
RSI: OversoldNov 2, 3:30 PM18 hours ago
SMA: BearishNov 2, 3:10 PM18 hours ago
MACD: Buy SignalNov 2, 2:45 PM18 hours ago
RSI: OversoldNov 2, 2:35 PM19 hours ago
RSI: OversoldNov 2, 2:15 PM19 hours ago
RSI: OversoldNov 2, 1:40 PM20 hours ago
MACD: Sell SignalNov 2, 1:30 PM20 hours ago
SMA: BearishNov 2, 1:15 PM20 hours ago
SMA: BearishNov 2, 1:10 PM20 hours ago
SMA: BullishNov 2, 1:05 PM20 hours ago
SMA: BullishNov 2, 1:00 PM20 hours ago
MACD: Buy SignalNov 2, 11:50 AM21 hours ago
SMA: BearishNov 2, 10:55 AM22 hours ago
SMA: BullishNov 2, 10:50 AM22 hours ago
SMA: BearishNov 2, 10:45 AM22 hours ago
SMA: BullishNov 2, 10:30 AM23 hours ago
SMA: BearishNov 2, 9:35 AM1 day ago
MACD: Sell SignalNov 2, 9:35 AM1 day ago

Newest 20 of 102.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 35.67 +321.6% upside
Target (low)
20.00
Target (mean)
35.67
Target (high)
45.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy10
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 14
  • 1 month ago 14
  • 2 months ago 16
  • 3 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BCAX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.82167-0.97 – -0.42-0.67-22.6%00.0%12
Next quarter-0.85417-0.97 – -0.47-0.68-25.6%00.0%12
Current year-3.39-3.68 – -2.65-2.52-34.4%00.0%12
Next year-3.52-4.73 – -1.86-3.39-4.0%00.0%11

Upgrades and downgrades

The latest rating changes

BCAX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 19, 2026BTIGReiteratedBuyBuy
Aug 19, 2026BMO CapitalInitiated—Outperform
Aug 12, 2026Goldman SachsMaintainedNeutralNeutral
Aug 12, 2026WedbushMaintainedOutperformOutperform
Aug 12, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 12, 2026MizuhoMaintainedNeutralNeutral
Aug 12, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Aug 12, 2026BTIGMaintainedBuyBuy
May 12, 2026Goldman SachsMaintainedNeutralNeutral
May 12, 2026Morgan StanleyMaintainedOverweightOverweight
May 11, 2026GuggenheimInitiated—Buy
Mar 31, 2026Goldman SachsMaintainedNeutralNeutral
Mar 31, 2026WedbushReiteratedOutperformOutperform
Mar 31, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Mar 31, 2026CitizensReiteratedMarket OutperformMarket Outperform
Mar 31, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 25, 2026B of A SecuritiesInitiated—Buy
Jan 29, 2026CitizensInitiated—Market Outperform
Jan 13, 2026WedbushReiteratedOutperformOutperform
Jan 8, 2026BTIGInitiated—Buy
Dec 18, 2025MizuhoInitiated—Neutral
Nov 11, 2025Wells FargoMaintainedEqual-WeightEqual-Weight
Aug 22, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 19, 2025Piper SandlerInitiated—Overweight
May 23, 2025Wells FargoUpgradeUnderweightEqual-Weight
May 16, 2025HC Wainwright & Co.MaintainedBuyBuy
Apr 17, 2025Wells FargoInitiated—Underweight
Apr 7, 2025HC Wainwright & Co.MaintainedBuyBuy
Mar 13, 2025Cantor FitzgeraldReiteratedOverweightOverweight
Feb 12, 2025WedbushReiteratedOutperformOutperform